ROLE OF FRAGILE SITES IN CHROMOSOME BREAKAGE AND CANCER
脆弱部位在染色体断裂和癌症中的作用
基本信息
- 批准号:3185312
- 负责人:
- 金额:$ 2.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-07-01 至 1994-12-31
- 项目状态:已结题
- 来源:
- 关键词:carcinogenesis cell transformation chromosome deletion chromosome disorders chromosome translocation cytogenetics developmental genetics gel electrophoresis gene expression genetic disorder diagnosis genetic mapping genetic markers genetic models human population genetics hybrid cells in situ hybridization leukemia lung neoplasms lymphoblast lymphoma neoplasm /cancer genetics proline small cell lung cancer tissue /cell culture transfection transposon /insertion element
项目摘要
The overall aims of this proposal are to clone and characterize DNA
sequences at the 3p14 fragile site (FRA3B). This fragile site will be
studied because of its contribution to chromosome structure and due to its
possible mechanistic involvement in chromosomal deletions seen in nearly
all small cell lung cancers and many renal cell tumors. We have previously
shown that this fragile site is a hot spot for chromosomal recombination as
measured by sister chromatid exchange analysis and the induction of
deletions and translocations at this site. As part of these experiments,
we have utilized somatic cell hybrids containing human chromosome 3 to
construct derivatives of this chromosome with deletions and translocations
at FRA3B. The translocations have occurred with hamster chromosomes. We
will use our translocation and deletion chromosomes as physical markers in
complementary reverse genetics approaches to clone the fragile sites. We
will attempt to identify the FRA3B fragile site translocation breakpoints
with pulsed-field gel electrophoresis (PFGE) using currently available
probes. We will also generate additional probes for this approach by
preparing linking libraries from irradiation-reduced hybrids containing
small segments of chromosome 3, including the fragile site, and physically
map these clones with conventional hybrid panels that minimize the region
around the fragile sites and by in situ hybridization. Once a probe is
identified within close physical distance by PFGE analysis, protocols of
chromosome jumping, cosmid walking and screening a general YAC library will
be utilized to move close to, and ultimately clone, the fragile site
sequences themselves. The irradiation-induced hybrids will be constructed
in such a manner as to facilitate a complementary direct cloning strategy.
Based on the observed high rate of chromosomal recombination at these
sites, we will test the hypothesis that a selectable marker (the neor gene)
can be inserted into the fragile sites and rescued together with flanking
DNA sequences. Detection of the insertion event will be accomplished in
part by co-segregation of the neor gene with DNA sequences close to FRA3B.
Fragile site clones will be characterized at the DNA and RNA levels and
tested in a series of biological experiments including testing for
variation in normal individuals, transfection experiments, and in a direct
test of the hypothesis that FRA3B plays a mechanistic role in chromosome
breakage and deletions of chromosome 3 in human tumors including small cell
carcinoma of the lung.
这项提案的总体目标是克隆和表征DNA
3p14脆性位点(FRA3B)。 这个脆弱的网站将是
研究是因为它对染色体结构的贡献,
可能的机制参与染色体缺失,
所有的小细胞肺癌和许多肾细胞肿瘤。 我们先前已经
表明这个脆性位点是染色体重组的热点,
通过姐妹染色单体交换分析和诱导
在这个位点上的缺失和易位。 作为这些实验的一部分,
我们已经利用含有人类3号染色体的体细胞杂交体,
构建带有缺失和易位的该染色体的衍生物
在FRA3B。 仓鼠的染色体发生了易位。 我们
将使用我们的易位和缺失染色体作为物理标记,
互补反向遗传学方法来克隆脆性位点。 我们
将尝试确定FRA3B脆性位点易位断裂点
脉冲场凝胶电泳(PFGE),使用目前可用的
probes. 我们还将为此方法生成其他探测器,
从辐射减少的杂交体制备连接文库,所述杂交体包含
3号染色体的小片段,包括脆性位点,
用传统的杂交板绘制这些克隆,
在脆性位点周围和通过原位杂交。 一旦探测器
通过PFGE分析在近物理距离内识别,
染色体跳跃、粘粒步移和筛选通用YAC文库将
被用来移动接近,并最终克隆,脆弱的网站,
序列本身。 将构建辐射诱导的杂交体
以便于辅助直接克隆策略。
根据在这些细胞中观察到的高染色体重组率,
位点,我们将测试的假设,一个选择标记(neor基因)
可以插入脆弱的网站和拯救一起侧翼
DNA序列 插入事件的检测将在
部分是由于neor基因与FRA3B附近的DNA序列共分离。
将在DNA和RNA水平表征脆性位点克隆,
在一系列生物实验中进行了测试,包括测试
在正常个体,转染实验中的变化,以及在直接
FRA3B在染色体中起机械作用的假设的检验
包括小细胞癌在内的人类肿瘤中3号染色体的断裂和缺失
肺癌
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS W GLOVER其他文献
THOMAS W GLOVER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS W GLOVER', 18)}}的其他基金
Cell cycle timing and molecular mechanisms of structural variant formation following incomplete replication
不完全复制后结构变异形成的细胞周期时间和分子机制
- 批准号:
10656861 - 财政年份:2023
- 资助金额:
$ 2.94万 - 项目类别:
Extreme genomic instability at large transcribed genes: mechanisms and consequences for the cancer genome
大转录基因的极端基因组不稳定性:癌症基因组的机制和后果
- 批准号:
9336863 - 财政年份:2016
- 资助金额:
$ 2.94万 - 项目类别:
Extreme genomic instability at large transcribed genes: mechanisms and consequences for the cancer genome
大转录基因的极端基因组不稳定性:癌症基因组的机制和后果
- 批准号:
9173540 - 财政年份:2016
- 资助金额:
$ 2.94万 - 项目类别:
Extreme genomic instability at large transcribed genes: mechanisms and consequences for the cancer genome
大转录基因的极端基因组不稳定性:癌症基因组的机制和后果
- 批准号:
9756149 - 财政年份:2016
- 资助金额:
$ 2.94万 - 项目类别:
De novo CNV formation in vivo with sickle cell anemia therapy
镰状细胞性贫血治疗体内从头形成 CNV
- 批准号:
8775671 - 财政年份:2012
- 资助金额:
$ 2.94万 - 项目类别:
De novo CNV formation in vivo with sickle cell anemia therapy
镰状细胞性贫血治疗体内从头形成 CNV
- 批准号:
8219623 - 财政年份:2012
- 资助金额:
$ 2.94万 - 项目类别:
De novo CNV formation in vivo with sickle cell anemia therapy
镰状细胞性贫血治疗体内从头形成 CNV
- 批准号:
8415873 - 财政年份:2012
- 资助金额:
$ 2.94万 - 项目类别:
De novo CNV formation in vivo with sickle cell anemia therapy
镰状细胞性贫血治疗体内从头形成 CNV
- 批准号:
8578098 - 财政年份:2012
- 资助金额:
$ 2.94万 - 项目类别:
Environmental Risk Factors for Copy Number Variation in Human Chromosomes
人类染色体拷贝数变异的环境风险因素
- 批准号:
7817619 - 财政年份:2009
- 资助金额:
$ 2.94万 - 项目类别:
Environmental Risk Factors for Copy Number Variation in Human Chromosomes
人类染色体拷贝数变异的环境风险因素
- 批准号:
7941810 - 财政年份:2009
- 资助金额:
$ 2.94万 - 项目类别:
相似海外基金
Elucidation of the pathogenesis of cancer stem cell transformation and acquisition of therapeutic resistance in lung cancer via the Hedgehog signaling system
通过 Hedgehog 信号系统阐明肺癌干细胞转化和获得治疗耐药性的发病机制
- 批准号:
23K08304 - 财政年份:2023
- 资助金额:
$ 2.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Deciphering the Role of Epstein-Barr Virus Molecular Mimicry and B cell Transformation in Multiple Sclerosis
解读 Epstein-Barr 病毒分子拟态和 B 细胞转化在多发性硬化症中的作用
- 批准号:
10568864 - 财政年份:2023
- 资助金额:
$ 2.94万 - 项目类别:
Mechanism of cell transformation by aconitase
乌头酸酶转化细胞的机制
- 批准号:
494625 - 财政年份:2023
- 资助金额:
$ 2.94万 - 项目类别:
Operating Grants
A novel treatment for eosinophilic otitis media by suppression of goblet cell transformation
通过抑制杯状细胞转化治疗嗜酸性中耳炎的新方法
- 批准号:
22K09710 - 财政年份:2022
- 资助金额:
$ 2.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the mechanism of lung cancer stem cell transformation and treatment resistance
阐明肺癌干细胞转化及治疗耐药机制
- 批准号:
21K16527 - 财政年份:2021
- 资助金额:
$ 2.94万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
proteomic analysis of smooth muscle cell transformation in obstructive lesions of pulmonary hypertension.
肺动脉高压阻塞性病变中平滑肌细胞转化的蛋白质组学分析。
- 批准号:
20K08155 - 财政年份:2020
- 资助金额:
$ 2.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Roles of the EMT transcription factors in epigenetic remodelling and myeloid cell transformation.
EMT 转录因子在表观遗传重塑和骨髓细胞转化中的作用。
- 批准号:
nhmrc : GNT1141081 - 财政年份:2018
- 资助金额:
$ 2.94万 - 项目类别:
Project Grants
Roles of the EMT transcription factors in epigenetic remodelling and myeloid cell transformation.
EMT 转录因子在表观遗传重塑和骨髓细胞转化中的作用。
- 批准号:
nhmrc : 1141081 - 财政年份:2018
- 资助金额:
$ 2.94万 - 项目类别:
Project Grants